| human | Q5 |
| P214 | VIAF ID | 176146707141200792029 |
| P10832 | WorldCat Entities ID | E39PBJmhTKpTvRyXvrjgtCHV4q |
| P735 | given name | Joachim | Q4926961 |
| Joachim | Q4926961 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q87372583 | "Sarcoidosis: recent advances" |
| Q99413069 | A Cluster of Beryllium Sensitization Traced to the Presence of Beryllium in Concrete Dust |
| Q43799756 | A genome-wide linkage analysis in 181 German sarcoidosis families using clustered biallelic markers. |
| Q28271903 | A novel sarcoidosis risk locus for Europeans on chromosome 11q13.1 |
| Q90920074 | A randomized trial of everolimus-based quadruple therapy vs standard triple therapy early after lung transplantation |
| Q40328974 | A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18. |
| Q36168860 | Acute exacerbations of idiopathic pulmonary fibrosis |
| Q42950741 | Alternatively activated alveolar macrophages in pulmonary fibrosis-mediator production and intracellular signal transduction |
| Q34447942 | An official American Thoracic Society statement: diagnosis and management of beryllium sensitivity and chronic beryllium disease |
| Q40545720 | Analysis of differentially regulated mRNAs in monocytic cells induced by in vitro stimulation with Kveim-Siltzbach test reagent |
| Q46684827 | Are bronchoalveolar lavages a good source for microbial profiling? Differences between throat and bronchoalveolar lavage microbiomes |
| Q37081313 | Association Study for 26 Candidate Loci in Idiopathic Pulmonary Fibrosis Patients from Four European Populations |
| Q46241033 | Atopobium and Fusobacterium as novel candidates for sarcoidosis-associated microbiota |
| Q34562135 | CC-chemokine ligand 18 induces epithelial to mesenchymal transition in lung cancer A549 cells and elevates the invasive potential |
| Q80238474 | CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis |
| Q48027626 | CCL18 production is decreased in alveolar macrophages from cigarette smokers |
| Q24813072 | CCR2 and CXCR3 agonistic chemokines are differently expressed and regulated in human alveolar epithelial cells type II. |
| Q38642800 | Cellular Players in the Immunopathogenesis of Sarcoidosis |
| Q36738614 | Circulating cytokines in sarcoidosis: phenotype-specific alterations for fibrotic and non-fibrotic pulmonary disease |
| Q35974078 | Common patterns and disease-related signatures in tuberculosis and sarcoidosis |
| Q96765830 | Comparison of reduced-toxicity conditioning protocols using fludarabine, melphalan combined with thiotepa or carmustine in allogeneic hematopoietic cell transplantation |
| Q48510953 | Correction: Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)? |
| Q90540423 | Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis |
| Q54735882 | Different gender-associated genotype risks of Wegener's granulomatosis and microscopic polyangiitis. |
| Q42616939 | Differential gene expression pattern in alveolar macrophages of patients with sarcoidosis and tuberculosis |
| Q40657495 | Emphysema- and airway-dominant COPD phenotypes defined by standardised quantitative computed tomography |
| Q81592735 | Eosinophilic cationic protein in bronchoalveolar lavage fluid of lung transplant patients |
| Q41676823 | Erratum for Maler et al., "Key Role of the Scavenger Receptor MARCO in Mediating Adenovirus Infection and Subsequent Innate Responses of Macrophages". |
| Q57244573 | Erratum: Corrigendum: Genome-wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis |
| Q37164171 | Essential role of osteopontin in smoking-related interstitial lung diseases |
| Q84510641 | Evidence-based recommendations in idiopathic pulmonary fibrosis: a year is a long time in interstitial lung disease |
| Q78443343 | Exaggerated TNFalpha release of alveolar macrophages in corticosteroid resistant sarcoidosis |
| Q51712561 | Female-specific association of C-C chemokine receptor 5 gene polymorphisms with Löfgren's syndrome. |
| Q45306477 | Function associated transforming growth factor-beta gene polymorphism in chronic beryllium disease |
| Q38290398 | Functional Toll-Like Receptor 9 Expression and CXCR3 Ligand Release in Pulmonary Sarcoidosis |
| Q81420986 | Genetics of sarcoidosis |
| Q87372590 | Genetics of sarcoidosis |
| Q34812481 | Genome-wide association analysis in sarcoidosis and Crohn's disease unravels a common susceptibility locus on 10p12.2. |
| Q28943511 | Genome-wide association analysis reveals 12q13.3-q14.1 as new risk locus for sarcoidosis |
| Q34928842 | Genome-wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis |
| Q24799118 | Genotyping in the MHC locus: potential for defining predictive markers in sarcoidosis |
| Q48516674 | German Guideline for Idiopathic Pulmonary Fibrosis - Update on Pharmacological Therapies 2017. |
| Q92290016 | High degree of polyclonality hinders somatic mutation calling in lung brush samples of COPD cases and controls |
| Q36916014 | High-Density Genetic Mapping Identifies New Susceptibility Variants in Sarcoidosis Phenotypes and Shows Genomic-driven Phenotypic Differences. |
| Q79755073 | IL-10-producing monocytes differentiate to alternatively activated macrophages and are increased in atopic patients |
| Q36128550 | Identification of Immune-Relevant Factors Conferring Sarcoidosis Genetic Risk |
| Q35708762 | Immune response to Propionibacterium acnes in patients with sarcoidosis--in vivo and in vitro |
| Q37776188 | Immunologic response of sarcoidosis |
| Q89380094 | Impact of Lung Function on Bronchiolitis Obliterans Syndrome and Outcome after Allogeneic Hematopoietic Cell Transplantation with Reduced-Intensity Conditioning |
| Q48424517 | Impact of impaired inspiratory muscle strength on dyspnea and walking capacity in sarcoidosis |
| Q33997625 | Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement |
| Q40136175 | Influence of lung CT changes in chronic obstructive pulmonary disease (COPD) on the human lung microbiome |
| Q39876461 | Inhaled vasoactive intestinal peptide exerts immunoregulatory effects in sarcoidosis. |
| Q39470428 | Insights from the German Compassionate Use Program of Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis |
| Q42489556 | Interleukin-18 expression by alveolar epithelial cells type II in tuberculosis and sarcoidosis |
| Q42366226 | Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)? |
| Q40098925 | Key Role of the Scavenger Receptor MARCO in Mediating Adenovirus Infection and Subsequent Innate Responses of Macrophages |
| Q59352285 | Kinetics of Torque Teno Virus-DNA Plasma Load Predict Rejection in Lung Transplant Recipients |
| Q35054029 | Lung collagens perpetuate pulmonary fibrosis via CD204 and M2 macrophage activation |
| Q34973462 | Macrophage activation in acute exacerbation of idiopathic pulmonary fibrosis |
| Q37585596 | Non-invasive biomarkers in pulmonary fibrosis |
| Q56212266 | Pathogenesis of sarcoidosis |
| Q47548972 | Phenotypes of organ involvement in sarcoidosis |
| Q46920626 | Phenotyping sarcoidosis from a pulmonary perspective |
| Q35619235 | Proteome analysis of bronchoalveolar lavage in pulmonary langerhans cell histiocytosis |
| Q57030954 | Psychometric properties of the German version of the Leicester Cough Questionnaire in sarcoidosis |
| Q91936526 | Publisher Correction: Sarcoidosis |
| Q30426245 | Rare and functional SIAE variants are not associated with autoimmune disease risk in up to 66,924 individuals of European ancestry |
| Q82836208 | Repeated segmental allergen provocation: reassessment of provocation dose |
| Q39499691 | Respiratory muscle function in interstitial lung disease. |
| Q28729156 | Roflumilast-N-oxide induces surfactant protein expression in human alveolar epithelial cells type II |
| Q96579774 | Safety and efficacy of abatacept in patients with treatment-resistant SARCoidosis (ABASARC) - protocol for a multi-center, single-arm phase IIa trial |
| Q86442315 | Sarcoidosis |
| Q95565170 | Sarcoidosis |
| Q84510734 | Sarcoidosis from bench to bedside: a state-of-the-art series for the clinician |
| Q34398412 | Sarcoidosis is associated with a truncating splice site mutation in BTNL2. |
| Q36748168 | Sarcoidosis--immunopathogenetic concepts |
| Q47703997 | Sarcoidosis: Drugs under Investigation. |
| Q83264263 | Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis |
| Q87798121 | Serum CCL18 is predictive for lung disease progression and mortality in systemic sclerosis |
| Q28728826 | Serum level of CC-chemokine ligand 18 is increased in patients with non-small-cell lung cancer and correlates with survival time in adenocarcinomas |
| Q87397287 | Specific antigen(s) in sarcoidosis: a link to autoimmunity? |
| Q57569188 | Study of C-C Chemokine Receptor 2 Alleles in Sarcoidosis, with Emphasis on Family-based Analysis |
| Q100297690 | Surveillance Bronchoscopy for the Care of Lung Transplant Recipients: A Retrospective Single Center Analysis |
| Q44547664 | Systemic immune cell activation in a subgroup of patients with idiopathic pulmonary fibrosis |
| Q53169870 | The EvA study: aims and strategy. |
| Q85166712 | The impact of gas exchange measurement during exercise in pulmonary sarcoidosis |
| Q54350647 | Toward the blood-borne miRNome of human diseases. |
| Q64055200 | Translation and psychometric properties of the King's Sarcoidosis Questionnaire (KSQ) in German language |
| Q35872012 | Tumor-cell co-culture induced alternative activation of macrophages is modulated by interferons in vitro |
| Q50971977 | Turning back the Wheel: Inducing Mesenchymal to Epithelial Transition via Wilms Tumor 1 Knockdown in Human Mesothelioma Cell Lines to Influence Proliferation, Invasiveness, and Chemotaxis. |
| Q33738931 | Update in diffuse parenchymal lung disease 2011 |
| Q39847893 | Usefulness of Cyclophosphamide Pulse Therapy in Interstitial Lung Diseases |
| Q96649225 | Vasoactive Intestinal Peptide in Checkpoint Inhibitor-Induced Pneumonitis |
| Q90582509 | Whole-exome sequencing identifies rare genetic variations in German families with pulmonary sarcoidosis |
| Q52837550 | [German Guideline for Idiopathic Pulmonary Fibrosis - Update on Pharmacological Therapies 2017]. |
| Q54157291 | [German Guideline for Idiopathic Pulmonary Fibrosis - Update on Pharmacological Therapies 2017]. |
Search more.